Intensive care unit management of fulminant hepatic failure

被引:6
作者
Gagliardi, G. [1 ]
Laccania, G. [1 ]
Boscolo, A. [1 ]
La Guardia, P. [1 ]
Arrigoni, M. [1 ]
Michielan, F. [1 ]
机构
[1] Univ Padua, Dept Anesthesiol & Intens Care, S Antonio Hosp, I-35100 Padua, Italy
关键词
D O I
10.1016/j.transproceed.2006.02.056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Objective. The aim of this open/retrospective study was to evaluate the outcomes of intensive care unit patients treated for fulminant hepatic failure (FHF) for predictive indices. Methods. All patients were recovered in the intensive care units with a diagnosis of FHF. We considered three groups of patients: (1) survivors, deceased, and transplanted. Subjects. All patients were fully screened, including liver function indices such as AST, ALT, total and bound bilirubin, albumin and pre-albumin, factors 5 and 7, alpha fetal protein (alpha-PP), other coagulation tests (PT, aPTT, INR, ATIII), and renal function (BUN and creatinine) parameters. For each patient Apache 11 score was calculated upon admission to the intensive care unit. Results. Apache 11 score showed efficacy. a-PP increased in both surviving and deceased, but not in the transplanted group. After intensive care unit admission, AST and ALT peaks were higher in the deceased DP than in the transplanted group. The INR value at the third day after ICU admission improved in the survivors compared with the other two cohorts. Factor 5 levels were lower among patients undergoing transplantation, but increased in the other two groups. The prognosis was strictly dependent upon the development of renal failure. Conclusion. The Apache 11 score was a sensitive predictive index for outcome. a-PP and factor 5 were not related to outcome, but useful for decision making when determining potential liver transplantation. INR can be used as a prognostic index. Intensive treatment beforehand is of primary importance to prevent multiple organ failure.
引用
收藏
页码:1389 / 1393
页数:5
相关论文
共 21 条
[1]
Early indicators of prognosis in fulminant hepatic failure: An assessment of the King's criteria [J].
Anand, AC ;
Nightingale, P ;
Neuberger, JM .
JOURNAL OF HEPATOLOGY, 1997, 26 (01) :62-68
[2]
BILIR BM, 1995, HEPATOLOGY, V26, P203
[4]
BRENDAN M, 2003, SEM GASTRO DIS, V14, P39
[5]
Clemmesen JO, 2001, AM J GASTROENTEROL, V96, P1217
[6]
DAVID A, 2003, GASTROENTEROL CLIN N, V32, P1195
[7]
A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure [J].
De Silvestro, G ;
Marson, P ;
Brandolese, R ;
Pittoni, G ;
Ongaro, G .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2000, 23 (07) :454-461
[8]
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure [J].
Demetriou, AA ;
Brown, RS ;
Busuttil, RW ;
Fair, J ;
McGuire, BM ;
Rosenthal, P ;
Esch, JSA ;
Lerut, J ;
Nyberg, SL ;
Salizzoni, M ;
Fagan, EA ;
de Hemptinne, B ;
Broelsch, CE ;
Muraca, M ;
Salmeron, JM ;
Rabkin, JM ;
Metselaar, HJ ;
Pratt, D ;
De La Mata, M ;
McChesney, LP ;
Everson, GT ;
Lavin, PT ;
Stevens, AC ;
Pitkin, Z ;
Solomon, BA .
ANNALS OF SURGERY, 2004, 239 (05) :660-667
[9]
IMPROVED OUTCOME OF PARACETAMOL-INDUCED FULMINANT HEPATIC-FAILURE BY LATE ADMINISTRATION OF ACETYLCYSTEINE [J].
HARRISON, PM ;
KEAYS, R ;
BRAY, GP ;
ALEXANDER, GJM ;
WILLIAMS, R .
LANCET, 1990, 335 (8705) :1572-1573
[10]
Hassanein T I, 1997, Ther Apher, V1, P33, DOI 10.1111/j.1744-9987.1997.tb00010.x